Recurrent Skin Cancer

Explore clinical trials studying Recurrent Skin Cancer. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Skin Cancer trial results

Completed

Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer

NCT02324608

Conditions: Neoplasms, Neoplasms by Site, Recurrent Skin Cancer, +4 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer

NCT00126555

Conditions: Neoplasms, Neoplasms by Site, Recurrent Skin Cancer, +4 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma

NCT01791894

Conditions: Basal Cell Carcinoma of the Skin, Carcinoma, Carcinoma, Basal Cell, +9 more
Locations: Stanford University Medical Center Stanford, California, United States

View Trial Details

Completed

Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)

NCT01631331

Conditions: Basal Cell Carcinoma of the Skin, Carcinoma, Carcinoma, Basal Cell, +9 more
Locations: Stanford University Stanford, California, United States

View Trial Details

Completed

T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant

NCT00089180

Conditions: Actinic Keratosis, Basal Cell Carcinoma of the Skin, Carcinoma, +14 more
Locations: UAB Comprehensive Cancer Center Birmingham, Alabama, United States

View Trial Details

Completed

Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

NCT00563290

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +21 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

Ohio State University Medical Center Columbus, Ohio, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer

NCT01292668

Conditions: Basal Cell Carcinoma of the Skin, Carcinoma, Carcinoma, Basal Cell, +13 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Recurrent Skin Cancer

Recurrent Skin Cancer trial results

Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer

Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer

Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma

Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)

T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant

Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer

Related conditions